Related Experiment Video

Updated: Jul 19, 2026

Immunometabolic Circuits in Infection for Advancing Host Directed Therapies
11:12

Immunometabolic Circuits in Infection for Advancing Host Directed Therapies

Published on: September 13, 2024

Unusual infections and novel therapy in the immunocompromised host

A C Gilleece1, L Fenelon

  • 1Department of Microbiology, St Vincents Hospital, Dublin, Ireland. lfenelon@svherc.ucd.ie

Current Opinion in Infectious Diseases
|October 13, 2006
PubMed

Insights

Immunocompromised patients face challenging infections from multiresistant bacteria and fungi. Recent advancements show progress in developing novel antimicrobial agents and alternative therapies to combat these difficult-to-treat pathogens.

Area of Science:

  • Infectious Diseases
  • Microbiology
  • Pharmacology

Background:

  • Immunocompromised patients are susceptible to opportunistic infections.
  • Unusual bacterial and fungal pathogens, often multiresistant, pose significant treatment challenges.
  • The rise of antimicrobial resistance necessitates the development of new therapeutic strategies.

Purpose of the Study:

  • To review recent progress in managing infections in immunocompromised individuals.
  • To highlight the emergence of difficult-to-treat pathogens.
  • To discuss advancements in antimicrobial agents and alternative therapies.

Main Methods:

  • Literature review of recent studies on infections in immunocompromised patients.
  • Analysis of reported cases involving unusual bacterial and fungal pathogens.
  • Evaluation of new antimicrobial drug development and alternative treatment modalities.

Main Results:

  • A significant number of infections in the past year were caused by uncommon, multiresistant bacteria and fungi.
  • These infections present considerable therapeutic difficulties.
  • Progress has been observed in the development of new antimicrobial agents and alternative therapies.

Conclusions:

  • Managing infections in immunocompromised patients remains a critical challenge.
  • Continued research and development of novel treatments are essential.
  • Advancements in antimicrobial agents and alternative therapies offer hope for improved patient outcomes.

Related Concept Videos

Cryptococcal Meningitis01:27

Cryptococcal Meningitis

Cryptococcal meningitis is a life-threatening opportunistic infection predominantly associated with HIV/AIDS, accounting for over 100,000 deaths annually worldwide. However, it also affects individuals with other forms of immunosuppression, including those undergoing immunosuppressive therapy, organ transplant recipients, patients with innate immunodeficiencies, and individuals with hematological disorders. The infection is caused mainly by Cryptococcus neoformans and Cryptococcus gattii,...
Immunodeficiency Diseases01:25

Immunodeficiency Diseases

Immunodeficiency disorders are conditions in which the immune system's ability to fight infectious disease and cancer is compromised or entirely absent. The immune system comprises a complex network of cells, tissues, and organs that work together to protect the body from potentially harmful invaders. When this system is deficient or not functioning properly, it leaves the body susceptible to infections, diseases, or other complications.
There are three main causes of immunodeficiency disorders...
Tumor Immunotherapy01:27

Tumor Immunotherapy

Immunotherapy is a treatment that boosts or manipulates the immune system to fight diseases, including cancer. For instance, by stimulating an immune response through vaccinations against viruses that cause cancers, like hepatitis B virus and human papillomavirus, these diseases can be prevented. Nonetheless, some cancer cells can avoid the immune system due to their rapid mutation and division. The immune response to many cancers involves three phases: elimination, equilibrium, and escape.
Pulmonary Tuberculosis I01:29

Pulmonary Tuberculosis I

Tuberculosis, often called TB, is a contagious illness primarily caused by Mycobacterium tuberculosis. It mainly affects the lung parenchyma but can also impact other body parts.
Causative Organism
The primary infectious agent causing tuberculosis is Mycobacterium tuberculosis, a slow-growing, acid-fast, aerobic rod that exhibits sensitivity to heat and ultraviolet light. Instances of Mycobacterium bovis and Mycobacterium avium contributing to the development of TB infection are rare.
Mode of...
Factors Affecting the Risk of Infection01:26

Factors Affecting the Risk of Infection

The hosts' susceptibility to infection depends on several factors. The integrity of the skin and mucous membranes helps protect the body against microbial attacks. When the skin is altered, the chance of infection, limb loss, and even death increases.
The integrity and count of the white blood cells help the body resist pathogens and fight infection. When impaired, it reduces the body's resistance to pathogens. The acidic pH levels of the gastrointestinal, genitourinary tracts, and skin create...
Trichomoniasis01:18

Trichomoniasis

Trichomonas vaginalis is a flagellated protozoan parasite and the causative agent of trichomoniasis, one of the most prevalent non-viral sexually transmitted infections in the United States. This extracellular parasite primarily colonizes the lower genitourinary tract in women—particularly the vagina—and in men, the urethra and prostate. Its structural and functional adaptations enable its survival, motility, and pathogenicity within the host environment.Structural Features and Host EntryT.